<DOC>
	<DOCNO>NCT02083562</DOCNO>
	<brief_summary>The purpose study ass association biomarkers day 7 life development bronchopulmonary dysplasia preterm infant . Additionally short lung function test 36 week postmenstrual age ( PMA ) perform investigate whether certain capnographic index able reflect degree lung disease .</brief_summary>
	<brief_title>Biomarkers Volumetric Capnography BPD</brief_title>
	<detailed_description>This two-centre prospective cohort study preterm infant bear 32 0/7 week PMA hospitalise neonatal intensive care unit University Children 's Hospital Basel Inselspital Berne two year . After informed consent sample 0.5 mL ethylenediaminetetraacetic acid ( EDTA ) full blood take day 7 life ( +/- 2 day ) routine blood sampling . The biomarkers plan measure include C-terminal portion proendothelin-1 precursor ( CT-proendothelin ( proET ) -1 ) plasma biomarkers respiratory distress . At 36 week PMA , lung function test perform quiet unsedated sleep supine position approximately 30 minute post feed . After placement facemask , tidal breathing record bedside use commercially available ultrasonic flow meter ( Spiroson , Exhalyzer D , Ecomedics , CH ) accord American Thoracic Society ( ATS ) European Respiratory Society ( ERS ) standard infant lung function test . Different capnographic index calculate investigate reflect degree lung disease 36 week PMA .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<criteria>parental consent , born 32 week PMA No parental consent , major lifethreatening anomaly ( cardiac defect , primary pulmonary malformation etc . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>9 Days</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Bronchopulmonary dysplasia , preterm infant</keyword>
</DOC>